Trials / Terminated
TerminatedNCT01030198
Laser Treatment for Fresh Surgical Scars and Mature Scars
Post-Market, Two-Arm, Single Blind, Controlled Study of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminum Garnet (EO QS Nd:YAG) Laser System for the Treatment of Scars
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Cynosure, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure the effectiveness of the RevLite Laser in the treatment of both fresh surgical scars and mature/older scars.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RevLite (Laser Treatment) |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-12-11
- Last updated
- 2020-12-17
- Results posted
- 2020-11-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01030198. Inclusion in this directory is not an endorsement.